Antivir Ther 2005, 10:441–449 PubMed 15 Stuyver L, Van Geyt C, D

Antivir Ther 2005, 10:441–449.PubMed 15. Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, Rossau R: Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy. J Clin Microbiol 2000, 38:702–707.PubMed 16. Tran N, Berne R, Chann R, Gauthier M, Martin D, Armand MA, Ollivet A, Teo CG, Ijaz S, Flichman D, et al.: European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and PD0332991 chemical structure identification of genotypes. J Clin Microbiol 2006, 44:2792–2800.PubMedCrossRef 17. Wang RS, Zhang H, Zhu YF, Han B, Yang ZJ: Detection

of YMDD mutants using universal template real-time PCR. World J Gastroenterol 2006, 12:1308–1311.PubMed 18. Malmstrom S, Hannoun C, Lindh M: Mutation analysis of lamivudine resistant hepatitis

B virus strains by TaqMan PCR. J Virol Methods 2007, 143:147–152.PubMedCrossRef 19. Solmone M, Vincenti D, Prosperi MC, Bruselles A, Ippolito G, Capobianchi MR: Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and Selleckchem LDC000067 drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol 2009, 83:1718–1726.PubMedCrossRef 20. Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, CBL0137 in vivo Holmes SP, Babrzadeh F, Gharizadeh B, Hanczaruk B, et al.: Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated

patients and NRTI-naive patients. J Infect Dis 2009, 199:1275–1285.PubMedCrossRef 21. Mello FCA, Fernandes CA, Gomes SA: Antiviral therapy against chronic hepatitis B in Brazil: High rates of lamivudine resistance mutations and correlation with HBV genotypes. Mem Inst Oswaldo Cruz 2012, 107:317–325.PubMedCrossRef 22. Moraes MT, Niel C, Gomes SA: A polymerase chain reaction-based assay to identify genotype F of hepatitis B virus. Braz J Med Biol Res 1999, 32:45–49.PubMedCrossRef 23. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through Sulfite dehydrogenase sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673–4680.PubMedCrossRef 24. Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596–1599.PubMedCrossRef 25. Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA: Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz 2006, 101:655–660.PubMedCrossRef 26.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>